OmniSpirant’s innovative technology platform aims to deliver inhaled gene therapy directly to the lung to treat the underlying cause of cystic fibrosis (CF)
A €12.8 million lung cancer project funded by Horizon Europe OmniSpirant Limited and EVerZom are delighted to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon
A €12.8 million lung cancer project funded by Horizon EuropePARIS (BUSINESS WIRE) OmniSpirant Limited and EVerZom are delighted to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. The project gathers European partners spanning across biotechnology, medical devices, canc.